MEDICA Newsletter
Social Media
More about…
- 3D printing and additive manufacturing
- Adiposity
- Age
- Alzheimer's
- Antibiotics
- Artificial intelligence
- Biocompatible
- Biomarker
- Biotechnology
- Blood
- Bones and skeleton
- Brain
- Brain Tumour
- Breast
- CT
- Cancer
- Cardiovascular diseases
- Care
- Cells
- Communication
- Dementia
- Depression
- Devices
- Diabetes
- Diagnostics
- Disinfection
- Drugs
- EEG
- EU
- Environment
- Epilepsy
- Eyes
- Financing
- Fitness
- Genetic material
- Genetics
- Germany
- Global health
- Gynecology
- Healthcare politics
- Heart
- Hospital
- Hospital information system
- Hygiene
- Imaging
- Immune system
- Implants
- Infectious diseases
- Information technology
- Intestine
- Kidney
- Knee
- Laboratory
- Laser
- Liver
- Lung
- MEDICA 2022
- MRI
- Mammography
- Materials
- Media
- Medical apps
- Medical market
- Microscopy
- Microtechnology
- Minimally invasive
- Multiple Sclerosis
- Nanotechnology
- Neurology
- Nuclear medicine
- Nutrition
- Optical technologies
- Optimisation
- Organs
- Orthopedics
- Pain
- Parkinson's
- Pathogens
- Pathology
- Patients
- Personalized Medicine
- Physiotherapy
- Pregnancy
- Prevention
- Prosthesis
- Psychology
- Radiology
- Regenerative Medicine
- Rehabilitation
- Research
- Risks
- Robotics
- SARS-CoV-2/COVID-19
- Safety
- Screening
- Screening
- Senses
- Skin
- Sleep
- Smart textiles
- Software
- Sports medicine
- Stem cells
- Sterilisation
- Surgery
- Surgical intervention
- Telemedicine
- Therapy
- Tissue engineering
- Transplantation
- Treatment
- Ultrasound
- Vaccination
- Virtual Reality and Augmented Reality
- Wearable technologies
- Women
- Wound care and wound healing
- X-ray devices
- eHealth
- mHealth
The University of Hong Kong
'Reduce and Remove': new treatment strategy for locally advanced liver cancer
19/01/2023
A pioneering phase II clinical study on tri-modality therapy (START-FIT), conducted by the Department of Surgery and Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has found that nearly 50% of patients with inoperable locally advanced liver cancer, can be cured through such an innovative approach.
Medical University of Vienna
Locally advanced cervical cancer: Better odds using personalized brachytherapy
17/01/2023
For the first time, a study conducted by a research group at the Comprehensive Cancer Centre Vienna of MedUni Vienna and Vienna General Hospital using data from the multicentre EMBRACE-I trial demonstrated the superiority of a targeted approach in brachytherapy.
sofiiashunkina
Complete package for minimally invasive tumor therapy
04/01/2023
License agreement and joint development: Fraunhofer MEVIS commences cooperation with Israeli partner for worldwide use of innovative software technology in ultrasound-aided tumor ablation.
Medtronic
VISUALASE: epilepsy surgery with the laser catheter
11/06/2019
Epilepsy patients are currently treated with either medication or surgical options. The aim is to remove the distinct regions of the brain that cause epileptic seizures. Laser ablation for epilepsy is a new, catheter-based surgical procedure that is now also available in Europe, preventing patients from having to undergo open brain surgery.